Ginsenosides from Panax ginseng differentially regulate lymphocyte proliferation.

Area of Science:

• Immunology
• Pharmacology
• Natural Products

Background:

• Panax ginseng C. A. Meyer, commonly known as ginseng, is a medicinal herb with a long history of use.
• Ginsenosides are the primary active compounds in ginseng, known for their diverse pharmacological activities.
• The immunomodulatory effects of ginsenosides are complex and require further elucidation.

Purpose of the Study:

• To investigate the immunosuppressive effects of specific ginsenosides (Rb1, Rb2, Re, Rg1) on CD4+ and CD8+ lymphocyte proliferation.
• To determine the differential impact of these ginsenosides on lymphocyte responses stimulated by various mitogens and cytokines.

Main Methods:

• Lymphocyte proliferation assays were performed using concanavalin A (Con A), lipopolysaccharide (LPS), phytohemagglutinin (PHA), and interleukin-2 (IL-2).
• The effects of ginsenosides Rb1, Rb2, Re, and Rg1 on CD4+ and CD8+ T cell proliferation were assessed.
• Inhibition concentrations (IC50) for proliferation and IL-2 production were determined for effective ginsenosides.

Main Results:

• Ginsenosides Rb1 and Re enhanced Con A-induced lymphocyte proliferation.
• Ginsenoside Rb2 significantly inhibited Con A, LPS, and PHA-induced lymphocyte proliferation (IC50: 21.8–29.0 microM) and Con A-stimulated IL-2 production (IC50: 13.3 microM).
• Ginsenosides Re and Rg1 demonstrated strong suppressive effects on IL-2-stimulated CD8+ T cell proliferation (IC50: 57.5–64.7 microM).

Conclusions:

• Ginsenosides from Panax ginseng exhibit differential immunomodulatory effects on lymphocyte proliferation.
• Ginsenoside Rb2 possesses significant immunosuppressive properties, affecting both T and B cell proliferation and IL-2 production.
• Ginsenosides Re and Rg1 selectively inhibit CD8+ T cell proliferation, suggesting distinct mechanisms of action.